» Articles » PMID: 36272408

The RIG-I Receptor Adopts Two Different Conformations for Distinguishing Host from Viral RNA Ligands

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2022 Oct 22
PMID 36272408
Authors
Affiliations
Soon will be listed here.
Abstract

RIG-I is an essential innate immune receptor for detecting and responding to infection by RNA viruses. RIG-I specifically recognizes the unique molecular features of viral RNA molecules and selectively distinguishes them from closely related RNAs abundant in host cells. The physical basis for this exquisite selectivity is revealed through a series of high-resolution cryo-EM structures of RIG-I in complex with host and viral RNA ligands. These studies demonstrate that RIG-I actively samples double-stranded RNAs in the cytoplasm and distinguishes them by adopting two different types of protein folds. Upon binding viral RNA, RIG-I adopts a high-affinity conformation that is conducive to signaling, while host RNA induces an autoinhibited conformation that stimulates RNA release. By coupling protein folding with RNA binding selectivity, RIG-I distinguishes RNA molecules that differ by as little as one phosphate group, thereby explaining the molecular basis for selective antiviral sensing and the induction of autoimmunity upon RIG-I dysregulation.

Citing Articles

Regulation and mechanisms of action of RNA helicases.

Lang N, Jagtap P, Hennig J RNA Biol. 2024; 21(1):24-38.

PMID: 39435974 PMC: 11498004. DOI: 10.1080/15476286.2024.2415801.


Mechanism of structure-specific DNA binding by the FANCM branchpoint translocase.

Abbouche L, Murphy V, Gao J, van Twest S, Sobinoff A, Auweiler K Nucleic Acids Res. 2024; 52(18):11029-11044.

PMID: 39189453 PMC: 11472164. DOI: 10.1093/nar/gkae727.


Recent developments in understanding RIG-I's activation and oligomerization.

Sikorska J, Wyss D Sci Prog. 2024; 107(3):368504241265182.

PMID: 39091074 PMC: 11297509. DOI: 10.1177/00368504241265182.


Proofreading mechanisms of the innate immune receptor RIG-I: distinguishing self and viral RNA.

Solotchi M, Patel S Biochem Soc Trans. 2024; 52(3):1131-1148.

PMID: 38884803 PMC: 11346460. DOI: 10.1042/BST20230724.


Dicer acts with the RIG-I-like helicase DRH-1 and RDE-4 to cleave dsRNA.

Consalvo C, Aderounmu A, Donelick H, Aruscavage P, Eckert D, Shen P Elife. 2024; 13.

PMID: 38747717 PMC: 11095941. DOI: 10.7554/eLife.93979.


References
1.
Chiang C, Beljanski V, Yin K, Olagnier D, Ben Yebdri F, Steel C . Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists. J Virol. 2015; 89(15):8011-25. PMC: 4505665. DOI: 10.1128/JVI.00845-15. View

2.
Ren X, Linehan M, Iwasaki A, Pyle A . RIG-I Selectively Discriminates against 5'-Monophosphate RNA. Cell Rep. 2019; 26(8):2019-2027.e4. DOI: 10.1016/j.celrep.2019.01.107. View

3.
Zivanov J, Nakane T, Scheres S . A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ. 2019; 6(Pt 1):5-17. PMC: 6327179. DOI: 10.1107/S205225251801463X. View

4.
Ghildiyal M, Zamore P . Small silencing RNAs: an expanding universe. Nat Rev Genet. 2009; 10(2):94-108. PMC: 2724769. DOI: 10.1038/nrg2504. View

5.
Taschuk F, Cherry S . DEAD-Box Helicases: Sensors, Regulators, and Effectors for Antiviral Defense. Viruses. 2020; 12(2). PMC: 7077277. DOI: 10.3390/v12020181. View